Airdate: Wednesday, July 27, 2022  Season: 9  Episode: 29

Guests: Peter Ansell, Marian Navratil

Play

In this episode of #ExpertAnswers, Dr. Peter Ansell from AbbVie and Dr. Marian Navratil from HTG answer questions from a webinar where they discuss the use of novel RNA-based gene expression profiling technologies for clinical and preclinical oncology research.

For more information or to watch the webinar, click here.

Associated Webinar: Integration of the HTG Transcriptome Panel into Preclinical and Clinical Programs to Drive Precision Medicine Research

You can listen to this podcast on:

Similar Podcasts

Related Content